14-23026165-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002797.5(PSMB5):c.716G>A(p.Arg239Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002797.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSMB5 | NM_002797.5 | c.716G>A | p.Arg239Gln | missense_variant | 3/3 | ENST00000361611.11 | NP_002788.1 | |
PSMB5 | NM_001130725.1 | c.407G>A | p.Arg136Gln | missense_variant | 3/3 | NP_001124197.1 | ||
PSMB5 | NM_001144932.3 | c.*189G>A | 3_prime_UTR_variant | 4/4 | NP_001138404.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSMB5 | ENST00000361611.11 | c.716G>A | p.Arg239Gln | missense_variant | 3/3 | 1 | NM_002797.5 | ENSP00000355325.6 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152130Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251482Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135916
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727248
GnomAD4 genome AF: 0.000171 AC: 26AN: 152248Hom.: 0 Cov.: 30 AF XY: 0.000188 AC XY: 14AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 22, 2023 | The c.716G>A (p.R239Q) alteration is located in exon 3 (coding exon 3) of the PSMB5 gene. This alteration results from a G to A substitution at nucleotide position 716, causing the arginine (R) at amino acid position 239 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at